Accumulating evidence indicated that UBE3C is implicated in several tumors, including glioma, melanoma, renal cell carcinoma, hepatocellular carcinoma, breast cancer, lung cancer, and gastric cancer (41,42,87-91). Here, UBE3C is linked to gastric cancer.